Operating Lease, Right-of-Use Asset of Edesa Biotech, Inc. from 30 Sep 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Edesa Biotech, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Sep 2019 to 30 Sep 2025.
  • Edesa Biotech, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $0, a 100% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Edesa Biotech, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $0 -$18,361 -100% 30 Sep 2025 10-K 12 Dec 2025 2025 FY
Q2 2025 $0 -$36,286 -100% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q3
Q1 2025 $0 -$54,972 -100% 31 Mar 2025 10-Q 14 May 2025 2025 Q2
Q4 2024 $0 -$74,885 -100% 31 Dec 2024 10-Q 14 Feb 2025 2025 Q1
Q3 2024 $18,361 -$73,012 -80% 30 Sep 2024 10-K 12 Dec 2025 2025 FY
Q2 2024 $36,286 -$76,101 -68% 30 Jun 2024 10-Q 09 Aug 2024 2024 Q3
Q1 2024 $54,972 -$73,418 -57% 31 Mar 2024 10-Q 10 May 2024 2024 Q2
Q4 2023 $74,885 -$71,649 -49% 31 Dec 2023 10-Q 09 Feb 2024 2024 Q1
Q3 2023 $91,373 +$72,908 +395% 30 Sep 2023 10-K 13 Dec 2024 2024 FY
Q2 2023 $112,387 +$73,350 +188% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q3
Q1 2023 $128,390 +$68,527 +114% 31 Mar 2023 10-Q 11 May 2023 2023 Q2
Q4 2022 $146,534 +$68,570 +88% 31 Dec 2022 10-Q 10 Feb 2023 2023 Q1
Q3 2022 $18,465 -$78,106 -81% 30 Sep 2022 10-K 15 Dec 2023 2023 FY
Q2 2022 $39,037 -$78,809 -67% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q3
Q1 2022 $59,863 -$74,389 -55% 31 Mar 2022 10-Q 13 May 2022 2022 Q2
Q4 2021 $77,964 -$72,449 -48% 31 Dec 2021 10-Q 14 Feb 2022 2022 Q1
Q3 2021 $96,571 -$63,435 -40% 30 Sep 2021 10-K 16 Dec 2022 2022 FY
Q2 2021 $117,846 -$54,930 -32% 30 Jun 2021 10-Q 13 Aug 2021 2021 Q3
Q1 2021 $134,252 -$47,240 -26% 31 Mar 2021 10-Q 14 May 2021 2021 Q2
Q4 2020 $150,413 -$63,435 -30% 31 Dec 2020 10-Q 16 Feb 2021 2021 Q1
Q3 2020 $160,006 +$160,006 30 Sep 2020 10-K 28 Dec 2021 2021 FY
Q2 2020 $172,776 30 Jun 2020 10-Q 12 Aug 2020 2020 Q3
Q1 2020 $181,492 31 Mar 2020 10-Q 15 May 2020 2020 Q2
Q4 2019 $213,848 31 Dec 2019 10-Q 13 Feb 2020 2020 Q1
Q3 2019 $0 30 Sep 2019 10-K 07 Dec 2020 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.